Psoriasis flare-ups following sorafenib therapy: A rare case

Ming Chun Hsu; Chih Chiang Chen

doi:10.1016/j.dsi.2016.01.004

Psoriasis flare-ups following sorafenib therapy: A rare case

Ming Chun Hsu, Chih Chiang Chen^*

^*此作品的通信作者

醫學系皮膚學科

研究成果: Article › 同行評審

5 引文斯高帕斯（Scopus）

摘要

Sorafenib is a multikinase inhibitor that blocks tumor cell proliferation and angiogenesis. While adverse skin reactions occur in 90% of patients treated with angiogenesis inhibitors, only a few cases of psoriasiform eruption associated with sorafenib therapy have been reported. We report a rare case of sorafenib-related psoriasis that responded well to topical treatment and narrow-band UV-B phototherapy after discontinuation of sorafenib.

原文	English
頁（從 - 到）	148-150
頁數	3
期刊	Dermatologica Sinica
卷	34
發行號	3
DOIs	https://doi.org/10.1016/j.dsi.2016.01.004
出版狀態	Published - 1 9月 2016

存取文件

10.1016/j.dsi.2016.01.004

其它文件與鏈接

Link to publication in Scopus

引用此

@article{cea5a3d3cd6e469195c58a5be6456e64,

title = "Psoriasis flare-ups following sorafenib therapy: A rare case",

abstract = "Sorafenib is a multikinase inhibitor that blocks tumor cell proliferation and angiogenesis. While adverse skin reactions occur in 90% of patients treated with angiogenesis inhibitors, only a few cases of psoriasiform eruption associated with sorafenib therapy have been reported. We report a rare case of sorafenib-related psoriasis that responded well to topical treatment and narrow-band UV-B phototherapy after discontinuation of sorafenib.",

keywords = "kinase inhibitor, psoriasiform eruption, psoriasis, sorafenib",

author = "Hsu, {Ming Chun} and Chen, {Chih Chiang}",

note = "Publisher Copyright: {\textcopyright} 2016",

year = "2016",

month = sep,

day = "1",

doi = "10.1016/j.dsi.2016.01.004",

language = "English",

volume = "34",

pages = "148--150",

journal = "Dermatologica Sinica",

issn = "1027-8117",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Psoriasis flare-ups following sorafenib therapy

T2 - A rare case

AU - Hsu, Ming Chun

AU - Chen, Chih Chiang

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Sorafenib is a multikinase inhibitor that blocks tumor cell proliferation and angiogenesis. While adverse skin reactions occur in 90% of patients treated with angiogenesis inhibitors, only a few cases of psoriasiform eruption associated with sorafenib therapy have been reported. We report a rare case of sorafenib-related psoriasis that responded well to topical treatment and narrow-band UV-B phototherapy after discontinuation of sorafenib.

AB - Sorafenib is a multikinase inhibitor that blocks tumor cell proliferation and angiogenesis. While adverse skin reactions occur in 90% of patients treated with angiogenesis inhibitors, only a few cases of psoriasiform eruption associated with sorafenib therapy have been reported. We report a rare case of sorafenib-related psoriasis that responded well to topical treatment and narrow-band UV-B phototherapy after discontinuation of sorafenib.

KW - kinase inhibitor

KW - psoriasiform eruption

KW - psoriasis

KW - sorafenib

UR - http://www.scopus.com/inward/record.url?scp=84959268575&partnerID=8YFLogxK

U2 - 10.1016/j.dsi.2016.01.004

DO - 10.1016/j.dsi.2016.01.004

M3 - Article

AN - SCOPUS:84959268575

VL - 34

SP - 148

EP - 150

JO - Dermatologica Sinica

JF - Dermatologica Sinica

SN - 1027-8117

IS - 3

ER -

Psoriasis flare-ups following sorafenib therapy: A rare case

摘要

存取文件

其它文件與鏈接

指紋

引用此